Lumida
/PCVX
⌘K
Vaxcyte Inc

Vaxcyte Inc

PCVX
$59.47USD+0.97%+0.57 today

MARKET CAP

8.8B

P/E (TTM)

FWD P/E

DAY RANGE

$58 – $60

52W RANGE

$31
$65

AI Summary

Stalk
Sell NowMedium

PCVX is exhibiting a bearish pivot breakdown in a Stage 4 downtrend, with the recent failure to reclaim the 9 and 20 EMAs signaling a shift toward structural repair. Medium-term bias remains bearish, reinforced by price below the 50 SMA and the active Bearish Pivot Point pattern. Short-term rejection at the 9/20 EMA resistance zone confirms that timing favors selling into rallies. Selling now into the 59.99–60.10 zone aligns with the Momentum + EPS strategy’s preference for participating in momentum breakdowns.

  • Vax31 may boost serotype coverage 45%, capturing market share
  • $3.13B cash runway underwrites R&D and ops through 2025
  • R&D expenses forecasted at $480M in 2025, pressuring cash
Full analysis →

Buying

12

institutions

Selling

8

institutions

New Positions

0

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY33.15 M1.92 B+19.76 M+210.9%0.47%
TR

T. Rowe Price Investment Management, Inc.

Q2 2026

BUY12.21 M709.62 M+81.43 K+0.7%0.47%
BI

Blackrock, Inc.

Q2 2026

BUY12.07 M701.52 M+1.10 M+10.0%0.01%
FC

Farallon Capital Management LLC

Q1 2026

BUY1.26 M73.28 M+1.26 M+31662.8%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.23 M71.19 M+219.03 K+28.5%0.00%
EP

Eversept Partners, LP

Q2 2026

SELL629.95 K36.62 M+-294.24 K-31.8%1.90%
CA

Citadel Advisors LLC

Q2 2026

BUY358.10 K20.82 M+160.50 K+81.3%0.00%
WP

Woodline Partners LP

Q2 2026

SELL274.74 K15.97 M+-274.74 K-50.0%0.05%
CP

California Public Employees Retirement System

Q2 2026

BUY212.47 K12.35 M+60.92 K+40.2%0.01%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL146.03 K8.49 M+-113.10 K-43.6%0.39%
MM

Millennium Management LLC

Q2 2026

SELL136.62 K7.94 M+-157.07 K-53.5%0.00%
MG

Man Group Plc

Q2 2026

BUY81.63 K4.75 M+62.38 K+324.1%0.01%
BA

Bridgewater Associates, LP

Q2 2026

BUY50.22 K2.92 M+37.31 K+289.3%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY34.56 K2.01 M+9.11 K+35.8%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL19.63 K1.14 M+-35.10 K-64.1%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY16.93 K984.43 K+5.29 K+45.5%0.01%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY10.13 K589.03 K+254.00+2.6%0.00%
BG

Baupost Group Llc/ma

Q2 2026

SELL0.000.00+-800.00 K-100.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-620.40 K-100.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL0.000.00+-514.58 K-100.0%0.00%